Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 10/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5837438 | 0.86 | EPHX2 (0.34) | CYP2D6CYP2C19ADAM17 | |
| SCHEMBL32688968 | 0.85 | CYP2D6 (0.42) | CYP2D6CYP2C19ADAM17MAPK1 | |
| SCHEMBL5836624 | 0.85 | CYP2D6 (0.35) | CYP2D6CYP2C19ADAM17MAPK1 | |
| SCHEMBL5837476 | 0.85 | CYP2D6 (0.35) | CYP2D6CYP2C19ADAM17MAPK1 | |
| SCHEMBL18621596 | 0.83 | POLA1 (0.36) | CYP2D6CYP2C19 | |
| SCHEMBL5837786 | 0.83 | ADAM17 (0.33) | CYP2D6CYP2C19ADAM17MAPK1 | |
| SCHEMBL7638350 | 0.82 | CYP2D6 (0.39) | CYP2D6CYP2C19 | |
| SCHEMBL5837506 | 0.82 | CYP2D6 (0.36) | CYP2D6CYP2C19ADAM17 | |
| SCHEMBL5838108 | 0.82 | CYP2D6 (0.36) | CYP2D6CYP2C19ADAM17 | |
| SCHEMBL5836976 | 0.80 | CYP2D6 (0.35) | CYP2D6CYP2C19ADAM17MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | AKT1 4059/4885CYP2D6 650/4885CYP2C19 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.